Moreover, Kaplan-Meier analysis indicated that patients with high E2F2-expressed gastric cancer tended to have worse overall survival than those with low E2F2-expressed tumor (p = 0.047, Figure 5H). This evidence concerns the gene E2F2 and neoplasm.